Latest News for: technetium 99m

Edit

Technetium-99m Market Poised for Growth, Projected to Reach Over US$ 8.6 Billion by 2034 | ...

Nasdaq Globe Newswire 28 Nov 2024
Technetium-99m is revolutionizing medical diagnostics, offering unmatched precision in imaging for a variety of diseases ... Technetium-99m is ...
Edit

Technetium Is In Short Supply. Here’s How That Affects Public Health

Forbes 24 Oct 2024
Technetium-99m is in short supply and could cause delays or cancellations of over 40,000 medical imaging studies daily in the United States ... .
Edit

Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer

The Manila Times 17 May 2024
Dr ... Previously, Dr ... (CLS) ... Dr ... Notably, he served as the Chief Scientific Investigator for the International Atomic Energy Agency's Coordinated Research Project on new methods for producing Technetium-99m (Tc-99m), a critical medical isotope ... Dr ... Dr ... "Dr.
Edit

B.C. medical isotope ‘trailblazer’ ARTMS fetches US$82M in Telix acquisition

North Shore News 11 Apr 2024
Australia’s Telix Pharmaceuticals Ltd ... ARTMS (pronounced like Artemis, the Greek goddess of the hunt) specializes in technology that produces the technetium-99m medical isotope ... These cyclotrons are found in most urban hospitals ... news@biv.com. .
Edit

Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform

The Eagle-Tribune 05 Mar 2024
... to support high efficiency and cost-effective production of commercially important medical isotopes including zirconium-89 (89Zr), gallium-68 (68Ga), technetium‐99m (99mTc) and copper-64 (64Cu).
Edit

Radiopharmaceuticals Market Targets US$ 9.5 Billion Milestone by 2032, Accelerating Growth in Nuclear Medicine

Pharmiweb 16 Feb 2024
... on an ELDA (Exclusive License and Distribution Agreement) for the latter’s diagnostic imaging agent called ‘Tilmanocept (technetium Tc 99m tilmanocept injection) in LATAM, Mexico, Canada, and the US.
Edit

US $13.7 Bn Radiopharmaceuticals Market – Global and Regional Analysis Report 2024-2032

Pharmiweb 26 Dec 2023
According to the report, the global radiopharmaceuticals industry generated $5.2 billion in 2022, and is anticipated to generate $13.7 billion by 2032, witnessing a CAGR of 10.2% from 2023 to 2032 ... Iodine I Gallium 68 Technetium 99m Fluorine 18 ... U.S ... .
Edit

Radiopharmaceuticals market size to grow by USD 4.37 billion from 2021 to 2026 | Actinium ...

Longview News-Journal 12 Dec 2023
NEW YORK, Dec ... Moreover, the market's growth momentum will accelerate at a CAGR of 9.9% ... SOC Ltd. and others ... Technetium-99m is the most common radioisotope used in diagnostic nuclear medicine and is used for the diagnosis of several types of cancers.
Edit

Radiopharmaceuticals market size to grow by USD 4.37 billion from 2021 to 2026 | The ...

Longview News-Journal 01 Dec 2023
NEW YORK, Dec ... Moreover, the market's growth momentum will accelerate at a CAGR of 9.9% ... Vendor landscape – ... Technetium-99m is the most common radioisotope used in diagnostic nuclear medicine and is used for the diagnosis of several types of cancers.
Edit

New CRP to Develop new Technetium-99m Radiopharmaceuticals for Disease Diagnosis (IAEA - International Atomic Energy Agency)

Public Technologies 24 Nov 2023
Despite advances in radiopharmaceuticals for diagnosis and therapy, technetium-99m (99mTc) radiopharmaceuticals are still the major diagnostic tools in clinical nuclear medicine worldwide.
Edit

Jubilant Pharmova stock gains 6.45% in an overall weak market; here's why

Live Mint 13 Nov 2023
... application (ANDA) submitted pursuant to Section 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C) for kit for the preparation of Technetium (Tc 99m) Sulfur Colloid Injection.Also Read.
Edit

Researchers produce Mo-99 by electron accelerator with optimized target system

Phys Dot Org 08 Nov 2023
The study was published in Applied Radiation and Isotopes. Mo-99 is the mother nuclide of technetium-99m (Tc-99m), which is widely used in diagnostic nuclear imaging procedures ... Many efforts have been made to find alternatives ... More information ... DOI ... ....
Edit

Thyroid Ablation Devices Market Update 2023: Predicted to Surpass USD 1.29 Billion by 2030, Report

Pharmiweb 16 Oct 2023
Radiopharmaceuticals Market by Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), by Application (Cancer, Cardiology, Others), by Type (Diagnostic, Therapeutic), by End ...
Edit

Radiopharmaceuticals Market Set to Achieve Astounding Value of US$ 9.5 Billion by 2032

Pharmiweb 04 Oct 2023
... on an ELDA (Exclusive License and Distribution Agreement) for the latter’s diagnostic imaging agent called ‘Tilmanocept (technetium Tc 99m tilmanocept injection) in LATAM, Mexico, Canada, and the US.
Edit

Radiopharmaceuticals Market Revenue to Cross USD 13.7 Billion by 2032: Allied Market Research

Pharmiweb 01 Sep 2023
What is the value of the radiopharmaceutical market? ... What are the major uses of radiopharmaceuticals?. Descriptions ... Iodine I Gallium 68 Technetium 99m Fluorine 18 ... On the basis of radioisotope, the Technetium-99m segment dominated the market in 2022 ... .

Most Viewed

×